|
1.
|
2025/05
|
|
Safety of iGlarLixi in Japanese People with Type 2 Diabetes: A Post-marketing Database Study
|
|
2.
|
2025/04/01
|
|
Handgrip strength in patients with type 2 diabetes correlates with diabetic polyneuropathy. A single-center, retrospective observational study in Japanese patients.
|
|
3.
|
2025/03/29
|
|
Blocking mineralocorticoid signaling with esaxerenone reduces atherosclerosis in hyperglycemic ApoE KO mice without affecting blood pressure and glycolipid metabolism
|
|
4.
|
2025/03/21
|
|
Efficacy and safety of imeglimin add-on to DPP-4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: An interim analysis of the randomised, double-blind FAMILIAR trial
|
|
5.
|
2025/03
|
|
Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia.
|
|
6.
|
2025/02
|
|
The onset of Type 3C diabetes mellitus in a young female due to distal pancreatectomy for solid pseudopapillary neoplasm
|
|
7.
|
2025/01/12
|
|
Long-term efficacy and safety of early sitagliptin initiation in subjects with type 2 diabetes: an extension of the SPIKE study
|
|
8.
|
2025/01
|
|
Clinical outcomes of immune checkpoint inhibitor-induced endocrine and other disorders in Japanese patients
|
|
9.
|
2025
|
|
A case of exacerbation of Graves' disease triggered by BNT162b2 vaccination
|
|
10.
|
2025
|
|
Continuously high titer of multiple islet-associated autoantibodies in an individual with the elderly onset of type 1 diabetes mellitus and Basedow’s disease: A case report and review of the literature
|
|
11.
|
2025
|
|
Development of a prediction model by combining tumor diameter and clinical parameters of adrenal incidentaloma
|
|
12.
|
2024/12
|
|
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β-cells and hepatic steatosis in obese type 2 diabetic db/db mice.
|
|
13.
|
2024/11
|
|
Insulin administration to an abdominal insulin ball that triggered the onset of diabetic ketoacidosis accompanied by Hamman’s syndrome in a patient with type 1 diabetes mellitus
|
|
14.
|
2024/10/26
|
|
Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching
|
|
15.
|
2024/10/21
|
|
Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study)
|
|
16.
|
2024/10/17
|
|
Comparison of Magnetic Resonance Imaging Features Between Programmed Cell Death 1/Programmed Cell Death Ligand 1 Inhibitor-Induced Hypopituitarism and Idiopathic Hypopituitarism in Japanese Subjects
|
|
17.
|
2024/10
|
|
A case of Sheehan syndrome with early postpartum panhypopituitarism and long-term partial improvement of endocrine function
|
|
18.
|
2024/09
|
|
Morphological Differences in the Abdominal Aorta Between Subjects With and Without Type 2 Diabetes
|
|
19.
|
2024/08
|
|
Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia
|
|
20.
|
2024/07
|
|
C-peptide index at 2 hour after meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes
|
|
21.
|
2024/07
|
|
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus
|
|
22.
|
2024/06
|
|
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice
|
|
23.
|
2024/06
|
|
The Impact of Hand Strength on HbA1c, Body Mass Index and Body Composition by Group According to Sedentary Behaviour: Cross-Sectional Study in Japanese Patients with Type 2 Diabetes Mellitus
|
|
24.
|
2024/05/23
|
|
Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis
|
|
25.
|
2024/04
|
|
The impact of grip strength, waist circumference, and body mass index on Hemoglobin A(1c) value: Cross-sectional study using outpatient clinical data in Japanese elderly patients with type 2 diabetes mellitus
|
|
26.
|
2024/03/19
|
|
Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ
|
|
27.
|
2024/03/08
|
|
A case of Empty Sella syndrome with adrenal insufficiency masked by prednisolone after administration of immune checkpoint inhibitors
|
|
28.
|
2024/01/08
|
|
Pathology of Kentoacidosis in Emergency of Diabetic Ketoacidosis and Alcoholic Ketoacidosis: A Retrospective Study
|
|
29.
|
2024/01/04
|
|
Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study
|
|
30.
|
2023/12
|
|
Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study)
|
|
31.
|
2023/10/21
|
|
Obstructive pneumonia with bronchial foreign body: A case report
|
|
32.
|
2023/09/20
|
|
Structural and functional differences in auto-antibody positive compared to auto-antibody negative hypothyroid patients with chronic thyroiditis
|
|
33.
|
2023/09/09
|
|
Comprehensive Search for GPCR Compounds which Can Enhance MafA and/or PDX-1 Expression Levels Using a Small Molecule Compound Library
|
|
34.
|
2023/09/05
|
|
Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study
|
|
35.
|
2023/08/17
|
|
Simple standing test without furosemide is useful in the diagnosis of primary aldosteronism
|
|
36.
|
2023/07/31
|
|
Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjects
|
|
37.
|
2023/07/28
|
|
Case Report: Repeated esophageal obstruction in a patient with type 3C diabetes mellitus
|
|
38.
|
2023/07/07
|
|
Case report: Acute submandibular sialadenitis in poorly controlled diabetes mellitus patient fed twenty days by enteral tube
|
|
39.
|
2023/07
|
|
Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study
|
|
40.
|
2023/06/22
|
|
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
|
|
41.
|
2023/05/16
|
|
Impact of nutritional guidance on various clinical parameters in patients with moderate obesity: A retrospective study
|
|
42.
|
2023/03/15
|
|
Influence of Nutritional Guidance/Consulting on Glycemic Control during the Coronavirus Disease 2019 Pandemic in Patients with Type 2 Diabetes Mellitus
|
|
43.
|
2023/01/30
|
|
A Male Subject with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Which Was Diagnosed at 31 Years Old due to Infertility
|
|
44.
|
2023/01/23
|
|
Incidence of endocrine-related immune-related adverse events in Japanese subjects with various types of cancer
|
|
45.
|
2022/12/21
|
|
Ectopic PTH-producing parathyroid cyst inside the thymus: a case report
|
|
46.
|
2022/12/16
|
|
Case report of severe hypoglycemic alcoholic ketoacidosis: A possible pitfall in diagnosis of ketoacidosis
|
|
47.
|
2022/12/01
|
|
A Case of Central Diabetes Insipidus due to Igg4-related Hypophysitis that Required Over One Year to Reach the Final Diagnosis due to Symptoms Being Masked by Sialadenitis
|
|
48.
|
2022/12
|
|
Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL)
|
|
49.
|
2022/10/27
|
|
Correlation of Baba's diabetic neuropathy classification with various diabetes-related complications
|
|
50.
|
2022/10/23
|
|
Addison's disease triggered by infection with mycobacterium abscessus, but not by adrenal tuberculosis or MAC pulmonary disease, in a subject with type 2 diabetes mellitus: case report
|
|
51.
|
2022/10/21
|
|
Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test
|
|
52.
|
2022/10/13
|
|
Association between changes in pancreatic morphology and vascular complications in subjects with type 2 diabetes mellitus: a retrospective study
|
|
53.
|
2022/10
|
|
Serious diabetic ketoacidosis induced by insulin allergy and anti-insulin antibody in an individual with type2 diabetes mellitus
|
|
54.
|
2022/09/17
|
|
Sudden extensive bloody pleural and pericardial effusion in a subject with untreated known hypothyroidism after total thyroidectomy, triggered by pneumonia
|
|
55.
|
2022/08/26
|
|
IgG4-related lung disease with multifocal pulmonary consolidations near the pleura: A case report
|
|
56.
|
2022/08/02
|
|
Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules
|
|
57.
|
2022/08
|
|
Adult acetonemic vomiting complicated with low body weight in a subject with Mycobacterium avium complex pulmonary disease: a case report
|
|
58.
|
2022/07/28
|
|
Clinical course of different long-acting insulin therapies-glargine U100, U300, degludec, and insulin degludec/insulin aspart-among Japanese patients with type 2 diabetes: a multicenter retrospective observational study (JDDM65 study)
|
|
59.
|
2022/07
|
|
Clinical course of different long-acting insulin therapies-glargine U100, U300, degludec, and insulin degludec/insulin aspart-among Japanese patients with type 2 diabetes: a multicenter retrospective observational study (JDDM65 study)
|
|
60.
|
2022/06
|
|
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials
|
|
61.
|
2022/05/12
|
|
Effect of hyperglycemia-related acute metabolic disturbance on thyroid function parameters in adults.
|
|
62.
|
2022/05
|
|
A pitfall in HbA1c measurement with high performance liquid chromatography in diagnosis of onset of fulminant type 1 diabetes mellitus.
|
|
63.
|
2022/04/13
|
|
Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation
|
|
64.
|
2022/04
|
|
Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
|
|
65.
|
2022/03/15
|
|
A case of prominent and persistent hypoglycemia by massive dose administration of long-acting insulin degludec: A possible pitfall in diabetes care.
|
|
66.
|
2022/03/03
|
|
Case Report: Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.
|
|
67.
|
2022/03
|
|
Acute respiratory distress syndrome triggered by marked cytokine storm in a subject with diabetic ketoacidosis: A case report
|
|
68.
|
2022/03
|
|
Case Report: A Patient With Neuroleptic Malignant Syndrome, Water Intoxication and Hyponatremia Associated With Severe Cerebral Edema and Coma
|
|
69.
|
2022/03
|
|
Case Report: Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
|
|
70.
|
2022/03
|
|
Case Report: Onset of Type 1 Diabetes Mellitus in a Patient With Ulcerative Colitis and Sjogren's Syndrome Under Euthyroid Hashimoto's Thyroiditis
|
|
71.
|
2022/03
|
|
Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes Mellitus
|
|
72.
|
2022/02
|
|
Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus
|
|
73.
|
2022/01
|
|
Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report
|
|
74.
|
2022/01
|
|
Edematous wall thickening of the gallbladder induced by hyperthyroidism
|
|
75.
|
2022/01
|
|
Vitamin D deficiency osteomalacia triggered by long-term social withdrawal and unbalanced diet in a Japanese middle-aged subject: A case report
|
|
76.
|
2022
|
|
A rare bronchial inflammatory polyp which caused massive hemoptysis but spontaneously disappeared in a subject with type 2 diabetes mellitus.
|
|
77.
|
2021/12
|
|
Association between Grit Scales and adherence to regular hospital visits among Japanese patients with type 2 diabetes: Prospective observational study
|
|
78.
|
2021/12
|
|
Case Report: Severe Edema and Marked Weight Gain Induced by Marginal Thiamine Deficiency in a Patient With Alcohol Dependency and Type 2 Diabetes Mellitus
|
|
79.
|
2021/12
|
|
Efficacy and safety of adding ipragliflozin to insulin in Japanese patients with type 1 diabetes mellitus: a retrospective study
|
|
80.
|
2021/12
|
|
Syndrome of inappropriate secretion of thyroid-stimulating hormone in a subject with galactorrhea and menstrual disorder and undergoing infertility treatment
|
|
81.
|
2021/11
|
|
Case Report: Markedly Long-Term Preservation of Pancreatic β-Cell Function in a Subject With Elderly Onset of Type 1 Diabetes Mellitus Showing High-Titer Autoimmune Antibodies for Over 4 Years
|
|
82.
|
2021/11
|
|
iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post-hoc analysis of the LixiLan JP-L trial
|
|
83.
|
2021/11
|
|
Primary Squamous Cell Carcinoma of the Thyroid with Severe Tracheal Invasion: A Case Report
|
|
84.
|
2021/10
|
|
Acute necrotic esophagitis accompanied by hyperglycemic hyperosmolar syndrome in a subject with type 2 diabetes mellitus.
|
|
85.
|
2021/10
|
|
Amelioration of hypercalcemia by cinacalcet treatment in a subject with relapsing acquired hypocalciuric hypercalcemia: A case report
|
|
86.
|
2021/10
|
|
Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency
|
|
87.
|
2021/09
|
|
Effects of sedentary behavior and daily walking steps on body mass index and body composition: Prospective observational study using outpatient clinical data of Japanese patients with type2 diabetes
|
|
88.
|
2021/09
|
|
Idiopathic bilateral extraocular myositis in a subject with poorly controlled type 2 diabetes mellitus:Case report
|
|
89.
|
2021/09
|
|
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
|
|
90.
|
2021/08/31
|
|
Formation of large abscess tumor including gallstone in ileum in a subject with hyperosmolar hyperglycemic syndrome.
|
|
91.
|
2021/08/12
|
|
Concurrence of overt Cushing’s syndrome and primary aldosteronism accompanied by aldosterone-producing cell cluster in adjacent adrenal cortex: case report
|
|
92.
|
2021/08/12
|
|
Multiple endocrine neoplasia type 1 with a frameshift mutation in its gene accompanied by a giant cervical lipoma and multiple fatty deposits in the pancreas: case report
|
|
93.
|
2021/08
|
|
Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
|
|
94.
|
2021/08
|
|
Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study
|
|
95.
|
2021/07
|
|
Clinical characteristics of withdrawal of basal insulin therapy among Japanese patients with type 2 diabetes: A multicenter retrospective observational study.
|
|
96.
|
2021/07
|
|
Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine
|
|
97.
|
2021/07
|
|
Pyogenic psoas abscess on the dorsal side, and bacterial meningitis and spinal epidural abscess on the ventral side, both of which were induced by spontaneous discitis in a patient with diabetes mellitus: A case report
|
|
98.
|
2021/06/25
|
|
Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
|
|
99.
|
2021/06/09
|
|
A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time
|
|
100.
|
2021/06
|
|
Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
|
|
101.
|
2021/06
|
|
Renal cell carcinoma sharply captured by imaging technology at an early stage in a hemodialysis patient: Usefulness of noninvasive monochrome superb microvascular imaging
|
|
102.
|
2021/05/04
|
|
Case Report: Various Abnormalities in Lipid and Glucose Metabolism Induced by Capecitabine
|
|
103.
|
2021/05/03
|
|
Primary Epstein–Barr virus infection shortly after primary Cytomegalovirus infection: a case report
|
|
104.
|
2021/05
|
|
Diabetic ketoacidosis and sinus arrest conditions in a patient with an inserted cardiac pacemaker
|
|
105.
|
2021/04
|
|
Case Report: Emphysematous Cystitis and Pyelonephritis Induced by Uterine Prolapse in a Subject With Untreated Diabetes Mellitus
|
|
106.
|
2021/03/22
|
|
Case Report: A Case of Pituitary Adenoma Producing Growth Hormone and Thyroid-Stimulating Hormone Simultaneously
|
|
107.
|
2021/03/17
|
|
Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic Class
|
|
108.
|
2021/03/05
|
|
Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History
|
|
109.
|
2021/03
|
|
Significance of body mass index for diagnosing sarcopenia is equivalent to slow gait speed in Japanese individuals with type 2 diabetes: Cross-sectional study using outpatient clinical data
|
|
110.
|
2021/01/14
|
|
Dulaglutide exerts beneficial anti atherosclerotic effects in ApoE knockout mice with diabetes: the earlier, the better
|
|
111.
|
2021/01/04
|
|
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
|
|
112.
|
2020/12/11
|
|
Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
|
|
113.
|
2020/12
|
|
Impact of sarcopenia on glycemic control and atherosclerosis in Japanese patients with type 2 diabetes: Cross-sectional study using outpatient clinical data
|
|
114.
|
2020/11/25
|
|
Primary Squamous Cell Carcinoma of the Thyroid with Severe Tracheal Invasion: A Case Report
|
|
115.
|
2020/11/20
|
|
Comparison in effects by three kinds of glucose-lowering drugs on nonalcoholic fatty liver disease in cases with type 2 diabetes: A randomized, open-label, 3-arm active-control study.
|
|
116.
|
2020/09/22
|
|
Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP-L randomized clinical trial
|
|
117.
|
2020/09/22
|
|
Fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge.
|
|
118.
|
2020/09/20
|
|
Benefits of the fixed‐ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes: A subgroup and time‐to‐control analysis of the LixiLan JP phase 3 trials
|
|
119.
|
2020/09/15
|
|
Rapidly Exacerbating Autoimmune Hemolytic Anemia Together With Marked Cytokine Storm Triggered by Pneumonia Infection: A Case Report
|
|
120.
|
2020/08/05
|
|
Basedow's disease with associated features of Hashimoto's thyroiditis based on histopathological findings
|
|
121.
|
2020/08
|
|
Insulin allergy brought out 8 years after starting insulin therapy in a subject with type 1 diabetes mellitus
|
|
122.
|
2020/07/09
|
|
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
|
|
123.
|
2020/05/15
|
|
Association Between Severity of Diabetic Neuropathy and Success in Weight Loss During Hospitalization Among Japanese Patients with Type 2 Diabetes: A Retrospective Observational Study.
|
|
124.
|
2020/05
|
|
Impact of physical activity and sedentary time on glycated hemoglobin levels and body composition: Cross- sectional study using outpatient clinical data of Japanese patients with type 2 diabetes.
|
|
125.
|
2020/05
|
|
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open- label, randomised, active-controlled, phase 3a trial.
|
|
126.
|
2020/04/02
|
|
Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study.
|
|
127.
|
2020/02/19
|
|
Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP-L Randomized Clinical Trial.
|
|
128.
|
2020/01/31
|
|
Practical application of short-term intensive insulin therapy based on the concept of "treat to target" to reduce hypoglycaemia in routine clinical site.
|
|
129.
|
2019/12/01
|
|
Dramatic Improvement of Glycemic Control by Promptly Starting Steroid Therapy at an Early Stage of Autoimmune Pancreatitis in a Subject with Type 2 Diabetes
|
|
130.
|
2019/11/05
|
|
Alteration of ACTH and Cortisol Levels After Estradiol Valerate Treatment in a Male Subject With Gender Dysphoria: A Case Report.
|
|
131.
|
2019/09
|
|
Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus
|
|
132.
|
2019/09
|
|
Decreased plasma aldosterone levels in patients with type 2diabetes mellitus: A possible pitfall in diagnosis of primary aldosteronism.
|
|
133.
|
2019/08/30
|
|
Severe hypertriglyceridemia in a subject with disturbed life style and poor glycemic control without recurrence of acute pancreatitis: a case report.
|
|
134.
|
2019/07
|
|
Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice
|
|
135.
|
2019/06
|
|
Marked elevation of plasma procalcitonin levels in patients with diabetic ketoacidosis: A possible useful diagnostic biomarker
|
|
136.
|
2019/04
|
|
Idiopathic and isolated adrenocorticotropic hormone deficiency presenting as continuous epigastric discomfort without symptoms of hypoglycemia: a case report.
|
|
137.
|
2019/03
|
|
Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical data.
|
|
138.
|
2019/01
|
|
Acute exacerbation of chronic osteomyelitis triggered by aggravation of type 2 diabetes mellitus: a case report.
|
|
139.
|
2019/01
|
|
Association of the Glycemic Fluctuation as well as Glycemic Control with the Pancreatic beta-cell Function in Japanese Subjects with Type 2 Diabetes Mellitus.
|
|
140.
|
2019/01
|
|
Drug fever and acute inflammation from hypercytokinemia triggered by dipeptidyl peptidase-4 inhibitor vildagliptin.
|
|
141.
|
2019/01
|
|
Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.
|
|
142.
|
2019/01
|
|
Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.
|
|
143.
|
2019/01
|
|
Eicosapentaenoic acid/arachidonic acid ratio and weight loss during hospitalization for glycemic control among overweight Japanese patients with type 2 diabetes: a retrospective observational study.
|
|
144.
|
2019/01
|
|
Suppression of free fatty acid receptor 1 expression in pancreatic beta-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1
|
|
145.
|
2018/11
|
|
Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study
|
|
146.
|
2018/11
|
|
Pancreatic islet-autonomous insulin and smoothened-mediated signalling modulate identity changes of glucagon+ a-cells.
|
|
147.
|
2018/10
|
|
A rare case of large pyosalpinx in an elderly patient with well-controlled type 2 diabetes mellitus: a case report.
|
|
148.
|
2018/10
|
|
Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic beta-cells in db/db mice: The earlier and longer, the better.
|
|
149.
|
2018/09
|
|
A Case of Fulminant Type 1 Diabetes Mellitus Complicated with a Life-threatening Electrolyte Abnormality and Abnormal Electrocardiogram Findings.
|
|
150.
|
2018/09
|
|
Fulminant Type 1 Diabetes Mellitus Complicated with a Life-threatening Electrolyte Abnormality and Abnormal Electrocardiogram Findings
|
|
151.
|
2018/08
|
|
Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity
|
|
152.
|
2018/08
|
|
Saibokuto as a Possible Therapy for Type B Insulin Resistance Syndrome: The Disappearance of Anti-insulin Receptor Antibody and a Marked Amelioration of Glycemic Control by Saibokuto Treatment.
|
|
153.
|
2018/08
|
|
There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study.
|
|
154.
|
2018/06
|
|
Decreased plasma aldosterone levels in patients with type 2 diabetes mellitus: A possible pitfall in diagnosis of primary aldosteronism
|
|
155.
|
2018/06
|
|
Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long-term therapy for chronic inflammatory demyelinating polyneuropathy.
|
|
156.
|
2018/06
|
|
Onset of type 1 diabetes mellitus and heparin-induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome.
|
|
157.
|
2018/06
|
|
Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension.
|
|
158.
|
2018/05
|
|
Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis.
|
|
159.
|
2018/03
|
|
Saibokuto as a Possible Therapy for Type B Insulin Resistance Syndrome: The Disappearance of Anti-insulin Receptor Antibody and a Marked Amelioration of Glycemic Control by Saibokuto Treatment.
|
|
160.
|
2018/02
|
|
Hepatic Gi signaling regulates whole-body glucose homeostasis.
|
|
161.
|
2018/02
|
|
Hypoinsulinemic hypoglycemia triggered by liver injury in elderly subjects with low body weight: case reports.
|
|
162.
|
2018/02
|
|
Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism
|
|
163.
|
2018/01
|
|
Aggravation of diabetes mellitus triggered by acute exacerbation of chronic thyroiditis(Hashimoto's disease).
|
|
164.
|
2018/01
|
|
Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus.
|
|
165.
|
2018/01
|
|
Hepatic Gi signaling regulates whole-body glucose homeostasis
|
|
166.
|
2018/01
|
|
Non-clostridial gas gangrene in a patient with poorly controlled type 2 diabetes mellitus on hemodialysis.
|
|
167.
|
2018
|
|
Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis
|
|
168.
|
2017/11
|
|
Decreased GLP-1 receptor expression in endothelial and smooth muscle cells in diabetic db/db mice.
|
|
169.
|
2017/10
|
|
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.
|
|
170.
|
2017/09
|
|
Increase of cortisol / ACTH ratio after chronic treatment with liraglutide in subjects with type 2 diabetes mellitus.
|
|
171.
|
2017/08
|
|
Werner Syndrome and Diabetes Mellitus Accompanied by Adrenal Cortex Cancer.
|
|
172.
|
2017/06
|
|
Bilateral lower limb edema induced by rapid improvement of glycemic control with insulin therapy in a subject with poorly controlled type 2 diabetes
|
|
173.
|
2017/06
|
|
Hypoglycemic Coma Induced by the Use of Succinic Acid Cibenzoline in Frail Late-stage Elderly Subjects.
|
|
174.
|
2017/05
|
|
Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus.
|
|
175.
|
2017/05
|
|
Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus.
|
|
176.
|
2017/04
|
|
Clinical course of pituitary function and image in IgG4-related hypophysitis.
|
|
177.
|
2017/03
|
|
Beneficial effects of SGLT2 inhibitors for preservation of pancreatic B-cell function and reduction of insulin resistance.
|
|
178.
|
2017/03
|
|
Temporal lobe epilepsy associated with GAD autoimmunity.
|
|
179.
|
2017/02
|
|
Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet alpha-Cells Into beta-Cells In Vivo.
|
|
180.
|
2017/02
|
|
The presence of dementia as one of diabetic complications: Hyperglycemia, hypoglycemia and glycemic fluctuation are associated with the development of dementia.
|
|
181.
|
2017/01
|
|
Recovered expression of Pdx1 improves beta-cell failure in diabetic mice
|
|
182.
|
2017/01
|
|
Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus.
|
|
183.
|
2016/12
|
|
Influence of thyroid volume on the effect of methimazole in Japanese subjects with mild Graves' disease.
|
|
184.
|
2016/12
|
|
Sequential cleavage of insulin receptor by calpain 2 and r-secretase impairs insulin signalling.
|
|
185.
|
2016/12
|
|
Treatment of Mitochondrial Diabetes with a Peroxisome Proliferator-activated Receptor (PPAR)-gamma Agonist.
|
|
186.
|
2016/11
|
|
Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus.
|
|
187.
|
2016/11
|
|
Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia
|
|
188.
|
2016/11
|
|
Human serum albumin: Possible cause of insulin autoimmune syndrome.
|
|
189.
|
2016/09
|
|
Strawberry milk-like blood in a subject with diabetic lipemia: dramatic change to transparent color after insulin therapy.
|
|
190.
|
2016/08
|
|
Clinical effects of liraglutide are possibly influenced by hypertriglyceridemia and remaining pancreatic beta-cell function in subjects with type 2 diabetes mellitus.
|
|
191.
|
2016/07
|
|
Case of disseminated pyomyositis in poorly controlled type 2 diabetes mellitus with diabetic ketoacidosis.
|
|
192.
|
2016/07
|
|
Optimal cut-off value of alanine aminotransferase level to precisely estimate the presence of fatty liver in patients with poorly controlled type2 diabetes.
|
|
193.
|
2016/06
|
|
Hamman's syndrome triggered by the onset of type 1 diabetes mellitus accompanied by diabetic ketoacidosis.
|
|
194.
|
2016/06
|
|
Promising Diabetes Therapy Based on the Molecular Mechanism for Glucose Toxicity: Usefulness of SGLT2 Inhibitors As Well As Incretin-Related Drugs.
|
|
195.
|
2016/05
|
|
Case of iliopsoas abscess that was markedly recovered after percutaneous and surgical drainage in a patient with poorly controlled type 2 diabetes.
|
|
196.
|
2016/03
|
|
Appropriate therapy for type 2 diabetes mellitus in view of pancreatic B-cell glucose toxicity: the earlier
|
|
197.
|
2016/03
|
|
Influence of atherosclerosis-related risk factors on serum hs-CRP levels in type 2 diabetic patients: Comparison of their influence between in obese and non-obese subjects.
|
|
198.
|
2016/03
|
|
Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)
|
|
199.
|
2016/02
|
|
Hemodialysis Associated with Severe and Unpredictable Hypoglycemia
|
|
200.
|
2016/02
|
|
Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic B-cells in obese type 2 diabetic db/db mice.
|
|
201.
|
2016/02
|
|
Sustained expression of GLP-1 receptor differentially modulates B-cell functions in diabetic and nondiabetic mice.
|
|
202.
|
2016/01
|
|
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).
|
|
203.
|
2016/01
|
|
Ice cube tray-shaped insulin lipoatrophy throughout the abdomen in a subject with type 2 diabetes.
|
|
204.
|
2016/01
|
|
Significant elevation of serum dipeptidyl peptidase-4 activity in young-adult type 1 diabetes.
|
|
205.
|
2016
|
|
Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β-cell glucose toxicity: "the earlier, the better"
|
|
206.
|
2016
|
|
Seven-year Observational Study on the Association between Glycemic Control and the New Onset of Macroangiopathy in Japanese Subjects with Type 2 Diabetes
|
|
207.
|
2015/11
|
|
Activation of GLP-1 and gastrin signalling induces in vivo reprogramming of pancreatic exocrine cells into beta cells in mice.
|
|
208.
|
2015/11
|
|
Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key B-cell factors under diabetic conditions.
|
|
209.
|
2015/09
|
|
Combination of DPP-4 inhibitor and PPARr agonist exerts protective effects on pancreatic beta-cells in diabetic db/db mice through the augmentation of IRS-2 expression.
|
|
210.
|
2015/09
|
|
Pancreatic Inflammation Captured by Imaging Technology at the Onset of Fulminant Type 1 Diabetes.
|
|
211.
|
2015/08
|
|
Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)
|
|
212.
|
2015/07
|
|
Pseudoaldosteronism induced by Yokukansan in an elderly Japanese type 2 diabetes mellitus patient with Alzheimer's disease.
|
|
213.
|
2015/06
|
|
Anti-hypertensive azelnidipine preserves insulin signaling and glucose uptake against oxidative stress in 3T3-L1 adipocytes
|
|
214.
|
2015/06
|
|
Low bilirubin levels are an independent risk factor for diabetic retinopathy and nephropathy in Japanese patients with type 2 diabetes.
|
|
215.
|
2015/06
|
|
The usefulness of a cholesterol absorption inhibitor in Japanese type 2 diabetic patients with dyslipidemia.
|
|
216.
|
2015/05
|
|
Case of newly onset type 1 diabetes after highly active antiretroviral therapy against HIV infection.
|
|
217.
|
2015/05
|
|
Rapid onset of syndrome of inappropriate antidiuretic hormone secretion induced by duloxetine in an elderly type 2 diabetic patient with painful diabetic neuropathy.
|
|
218.
|
2015/04
|
|
A case of hypothalamic hypopituitarism accompanied by recurrent severe hypoglycemia.
|
|
219.
|
2015/03
|
|
Preserving MafA expression in diabetic islet beta-cells improves glycemic control in vivo
|
|
220.
|
2015/03
|
|
Role of pancreatic transcription factors in maintenance of mature beta-cell function
|
|
221.
|
2015/01
|
|
A case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated
|
|
222.
|
2015/01
|
|
Protective effects of pioglitazone and/or liraglutide on pancreatic B-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes
|
|
223.
|
2015
|
|
A case of disseminated pyomyositis in poorly controlled type 2 diabetes with diabetic ketoacidosis.
|
|
224.
|
2015
|
|
Case of iliopsoas abscess which was markedly recovered after percutaneous and surgical drainage in a subject with poorly controlled type 2 diabetes.
|
|
225.
|
2015
|
|
Optimal cut-off value of ALT level to precisely estimate the presence of fatty liver in subjects with poorly controlled type 2 diabetes.
|
|
226.
|
2015
|
|
Pancreatic beta-cell glucose toxicity in type 2 diabetes mellitus.
|
|
227.
|
2014/02
|
|
Sequential introduction and dosage balance of defined transcription factors affect reprogramming efficiency from pancreatic duct cells into insulin-producing cells.
|
|
228.
|
2014/01
|
|
A case of aniridia with a heterozygous PAX6 mutation whose pituitary function was partially impaired.
|
|
229.
|
2014/01
|
|
Assessment of vibratory sensation with tuning fork at different sites in Japanese patients with diabetes mellitus.
|
|
230.
|
2014/01
|
|
Carotid ultrasonography: a potent tool for better clinical practice of atherosclerosis in diabetic patients.
|
|
231.
|
2014/01
|
|
Prediction for the presence of insulin resistance by general health check-up data in Japanese employees with metabolic risk factors.
|
|
232.
|
2014
|
|
Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes: an 8-year prospective study
|
|
233.
|
2014
|
|
Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia
|
|
234.
|
2014
|
|
Shared and additional risk factors for decrease of toe-brachial index compared to ankle-brachial index in Japanese patients with diabetes mellitus
|
|
235.
|
2014
|
|
The risk factors associated with ultrasonic tissue characterization of carotid plaque in type 2 diabetic patients
|
|
Display 5 items
|
|
Display all(235)
|
